Market access and value-based pricing of digital health applications in Germany

被引：0
|
作者：
Daniel Gensorowsky
Julian Witte
Manuel Batram
Wolfgang Greiner
机构：
[1] Bielefeld University,School of Public Health, Department of Health Economics and Health Care Management
[2] Vandage GmbH,undefined
来源：
Cost Effectiveness and Resource Allocation | / 20卷
关键词：
Digital health applications; DiGA; eHealth; Statutory health insurance; Market access; Value-based pricing; Fast-track process;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In December 2019, the Digital Health Care Act (“Digitale-Versorgung-Gesetz”) introduced a general entitlement to the provision and reimbursement of digital health applications (DiGA) for insured persons in the German statutory health insurance. As establishing a new digital service area within the solidarity-based insurance system implies several administrative and regulatory challenges, this paper aims to describe the legal framework for DiGA market access and pricing as well as the status quo of the DiGA market. Furthermore, we provide a basic approach to deriving value-based DiGA prices.
引用
收藏
相关论文
共 50 条
  • [1] Market access and value-based pricing of digital health applications in Germany
    Gensorowsky, Daniel
    Witte, Julian
    Batram, Manuel
    Greiner, Wolfgang
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2022, 20 (01)
  • [2] AN APPROACH TO VALUE- BASED PRICING FOR DIGITAL HEALTH APPLICATIONS IN GERMANY
    Gensorowsky, D.
    Witte, J.
    Batram, M.
    Greiner, W.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S72 - S73
  • [3] The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems
    Pauly, Mark V.
    [J]. VALUE IN HEALTH, 2017, 20 (02) : 278 - 282
  • [4] Market signals in value-based pricing premiums and discounts
    Feuz, DM
    [J]. JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS, 1999, 24 (02): : 327 - 341
  • [5] Value-Based Pricing and Patient Access for Specialty Drugs
    Robinson, James C.
    Howell, Scott
    Pearson, Steven D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (21): : 2169 - 2170
  • [6] COMPARISON OF MARKET ACCESS ROUTES OF DIGITAL HEALTH APPLICATIONS IN FRANCE, GERMANY AND THE UK
    Vollmer, L.
    Foxon, G.
    Danev, V
    Berard, I
    Benazet, F.
    Walzer, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S579 - S579
  • [7] REGULATION AND REALITY OF THE MARKET ACCESS PROCESS FOR DIGITAL HEALTH APPLICATIONS (DIGA) IN GERMANY
    Koerber, F.
    Schneider, B.
    Kreuzenbeck, C.
    Brenner, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S266 - S266
  • [8] Effects of market orientation, innovation strategies and value-based pricing on market performance
    De Toni, Deonir
    Reche, Ricardo Antonio
    Milan, Gabriel Sperandio
    [J]. INTERNATIONAL JOURNAL OF PRODUCTIVITY AND PERFORMANCE MANAGEMENT, 2022, 71 (08) : 3556 - 3580
  • [9] Grounding Value-Based Drug Pricing in Population Health
    Kaltenboeck, Anna
    Calsyn, Maura
    Frederix, Geert W. J.
    Lowenthal, Justin
    Mitchell, David
    Rector, Bruce
    Sarpatwari, Ameet
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1290 - 1292
  • [10] HEALTH TECHNOLOGY ASSESSMENT AND VALUE-BASED PRICING IN GERMANY, THE UNITED KINGDOM AND FRANCE: RECENT DEVELOPMENTS AND IMPLICATIONS
    Hao, Y.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A261 - A261
12345